Back to Journals » Cancer Management and Research » Volume 9

Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting

Total article views   HTML views PDF downloads Totals
11,573 Dovepress* 9,899+ 1,829 11,728
PubMed Central* 1,674 701 2,375
Totals 11,573 2,530 14,103
*Since 21 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 2 3

View citations on PubMed Central and Google Scholar